Skip to main content
. 2025 Jan 22;27(6):1519–1535. doi: 10.1093/neuonc/noaf015

Table 2.

Univariate and multivariate analysis of prognostic factors for death in patients with diffuse hemispheric glioma, H3 G34 mutant (Cox regression).

Univariate analysis Multivariate analysis
n (events) HR (95 % CI) P value n
(events)
HR (95 % CI) P value
Age
 <18 years 26 (18) 1.42 (0.82-2.44) .212 13 (9) 1.58 (0.71-3.52) .261
 ≥18 years 86 (53) 1 ref 61 (38) 1 ref
Sex
 Female 38 (17) 0.40 (0.23-0.69) .001 31 (12) 0.43 (0.21-0.87) .019
 Male 74 (54) 1 ref 43 (35) 1 ref
KPS
 <70% 14 (9) 1.92 (0.90-4.08) .092 11 (8) 1.05 (0.32-3.45) .937
 70-80% 27 (17) 1.20 (0.66-2.20) .552 24 (15) 0.94 (0.43-2.06) .879
 90-100% 45 (29) 1 ref 39 (24) 1 ref
 No data 26 - - -
Extent of resection
 Gross total 37 (25) 0.52 (0.29-0.93) .028 28 (19) 0.31 (0.12-0.79) .014
 Incomplete 33 (21) 0.77 (0.42-1.40) .384 22 (15) 0.40 (0.16-1.05) .062
 Biopsy/Autopsy 35 (22) 1 ref 24 (13) 1 ref
 No data 7 - - -
MGMT promoter status
 Methylated 77 (43) 0.52 (0.30-0.89) .018 53 (29) 0.51 (0.23-1.13) .098
 Unmethylated 26 (20) 1 ref 21 (18) 1 ref
 No data 9 - - -
First-line treatment
 No therapy 6 (4) 1 ref 4 (4) 1 ref
 Any therapy 99 (63) 0.02 (0.03-0.70) <.001 70 (43) 0.27 (0.03-0.14) <.001
 No data 7 - - -

Survival data are missing in N = 2 patients.

CI, confidence interval; HR, hazard ratio; KPS, Karnofsky performance status; MGMT, O6-methylguanine DNA methyltransferase.